Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Sep 15  •  04:00PM ET
131.33
Dollar change
-2.40
Percentage change
-1.79
%
IndexS&P 500 P/E16.42 EPS (ttm)8.00 Insider Own0.67% Shs Outstand1.74B Perf Week-0.66%
Market Cap228.57B Forward P/E23.15 EPS next Y5.67 Insider Trans-0.07% Shs Float1.73B Perf Month1.59%
Enterprise Value234.99B PEG1.59 EPS next Q1.30 Inst Own80.17% Short Float1.03% Perf Quarter-3.16%
Income13.94B P/S5.30 EPS this Y10.21% Inst Trans0.46% Short Ratio2.78 Perf Half Y3.65%
Sales43.11B P/B4.52 EPS next Y10.21% ROA17.75% Short Interest17.75M Perf YTD16.11%
Book/sh29.05 P/C31.39 EPS next 5Y10.30% ROE31.01% 52W High141.23 -7.01% Perf Year12.63%
Cash/sh4.18 P/FCF33.74 EPS past 3/5Y24.73% 29.98% ROIC21.95% 52W Low110.86 18.46% Perf 3Y22.75%
Dividend Est.2.39 (1.82%) EV/EBITDA21.94 Sales past 3/5Y-0.88% 5.63% Gross Margin51.83% Volatility2.49% 1.70% Perf 5Y27.70%
Dividend TTM2.32 (1.77%) EV/Sales5.45 EPS Y/Y TTM152.28% Oper. Margin17.56% ATR (14)2.49 Perf 10Y204.92%
Dividend Ex-DateJul 15, 2025 Quick Ratio1.30 Sales Y/Y TTM5.85% Profit Margin32.33% RSI (14)49.30 Recom1.91
Dividend Gr. 3/5Y7.17% 11.16% Current Ratio1.82 EPS Q/Q38.82% SMA20-0.44% Beta0.70 Target Price142.79
Payout29.33% Debt/Eq0.27 Sales Q/Q7.37% SMA500.73% Rel Volume0.63 Prev Close133.73
Employees114000 LT Debt/Eq0.26 EarningsJul 17 BMO SMA2002.56% Avg Volume6.38M Price131.33
IPOMar 01, 1937 Option/ShortYes / Yes EPS/Sales Surpr.0.33% 0.45% Trades Volume4,050,918 Change-1.79%
Date Action Analyst Rating Change Price Target Change
Jul-18-25Upgrade Jefferies Hold → Buy $145
Jun-16-25Initiated Leerink Partners Market Perform $143
Oct-08-24Initiated Oppenheimer Outperform $130
Sep-19-24Initiated Piper Sandler Overweight $131
Jul-30-24Downgrade Edward Jones Buy → Hold
May-30-24Initiated Goldman Buy $121
Jul-21-23Upgrade Wolfe Research Underperform → Peer Perform
May-30-23Downgrade Morgan Stanley Overweight → Equal-Weight $112
Apr-20-23Reiterated Wolfe Research Underperform $107 → $103
Apr-20-23Reiterated UBS Buy $117 → $130
Sep-13-25 06:42AM
Sep-11-25 06:48PM
Sep-10-25 05:50PM
11:40AM
Sep-09-25 09:05AM
04:51PM Loading…
Sep-08-25 04:51PM
Sep-07-25 02:37PM
Sep-05-25 08:50AM
Sep-04-25 08:47AM
04:09AM
Sep-03-25 07:00AM
05:55AM
Sep-02-25 04:25PM
11:06AM
Sep-01-25 12:11PM
09:54AM Loading…
09:54AM
09:54AM
Aug-31-25 01:36PM
Aug-29-25 09:48AM
08:00AM
Aug-28-25 12:01AM
Aug-27-25 12:50PM
12:38PM
08:55AM
08:40AM
Aug-26-25 05:13AM
Aug-25-25 11:40AM
08:49AM
Aug-23-25 06:45AM
Aug-22-25 11:30AM
06:07AM Loading…
Aug-21-25 06:07AM
Aug-20-25 08:40PM
11:20AM
11:20AM
09:30AM
Aug-19-25 09:00AM
Aug-18-25 09:00AM
08:50AM
Aug-15-25 10:00AM
12:40AM
Aug-14-25 09:50AM
08:33AM
Aug-13-25 10:11AM
09:21AM
08:37AM
Aug-12-25 05:37AM
05:32AM
04:49AM
04:42AM
Aug-11-25 12:07PM
10:02AM
08:48AM
Aug-09-25 06:45AM
Aug-08-25 09:39AM
08:43AM
07:56AM
Aug-07-25 11:40AM
10:16AM
05:39AM
Aug-06-25 04:05PM
04:05PM
09:00AM
07:41AM
Aug-05-25 11:32PM
Aug-01-25 08:15AM
Jul-31-25 03:26PM
12:23AM
Jul-30-25 05:08AM
Jul-29-25 01:43PM
10:02AM
04:38AM
04:31AM
04:02AM
Jul-28-25 08:09AM
02:08AM
01:42AM
Jul-27-25 03:00PM
Jul-25-25 11:50PM
07:00PM
01:11PM
11:13AM
05:27AM
Jul-24-25 09:38AM
09:06AM
05:00AM
Jul-23-25 05:06PM
10:54AM
09:00AM
04:30AM
Jul-22-25 01:30PM
11:40AM
08:32AM
08:30AM
Jul-21-25 12:30PM
08:43AM
06:13AM
06:02AM
05:22AM
05:20AM
Jul-20-25 12:15AM
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the line of branded generic pharmaceuticals manufactured worldwide and marketed and sold outside the United States in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternate care testing sites. The Nutritional Products segment caters to the worldwide sales of pediatric and adult nutritional products. The Medical Devices segment includes a broad line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care and continuous glucose monitoring products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Boudreau Philip PEVP AND CFOAug 08 '25Sale134.555,550746,75851,003Aug 11 05:53 PM
Boudreau Philip POfficerAug 08 '25Proposed Sale134.555,550746,758Aug 08 06:30 PM
Blount Sally E.DirectorApr 30 '25Sale129.662,600337,11634,058May 02 05:04 PM
SALLY E BLOUNTDirectorApr 30 '25Proposed Sale129.662,600337,116Apr 30 04:23 PM
Earnhardt Lisa DEVP AND GROUP PRESIDENTMar 06 '25Option Exercise80.9891,1677,382,704163,095Mar 07 06:55 PM
Earnhardt Lisa DEVP AND GROUP PRESIDENTMar 07 '25Option Exercise80.9820016,19672,128Mar 07 06:55 PM
Earnhardt Lisa DEVP AND GROUP PRESIDENTMar 06 '25Sale133.8291,16712,199,96871,928Mar 07 06:55 PM
Earnhardt Lisa DEVP AND GROUP PRESIDENTMar 07 '25Sale136.6520027,32971,928Mar 07 06:55 PM
Lisa D. EarnhardtOfficerMar 07 '25Proposed Sale136.6520027,329Mar 07 06:28 PM
Lisa D. EarnhardtOfficerMar 06 '25Proposed Sale133.8291,16712,199,967Mar 06 05:47 PM
Wainer Andrea FRETIRED EVPMar 03 '25Sale138.17949131,12374,381Mar 04 08:05 PM
Shroff EricSenior Vice PresidentMar 03 '25Sale138.1756277,65231,970Mar 04 08:00 PM
Morrone Louis H.EXECUTIVE VICE PRESIDENTMar 03 '25Sale138.171,111153,50766,878Mar 04 07:49 PM
Moreland Mary KEXECUTIVE VICE PRESIDENTMar 03 '25Sale138.17791109,29295,583Mar 04 07:44 PM
MCCOY JOHN A. JR.VICE PRESIDENT AND CONTROLLERMar 03 '25Sale138.1756277,65221,061Mar 04 07:39 PM
Eric ShroffOfficerMar 03 '25Proposed Sale138.1756277,651Mar 03 08:40 PM
Andrea F. WainerRetired OfficerMar 03 '25Proposed Sale138.17949131,123Mar 03 08:18 PM
Louis H. MorroneOfficerMar 03 '25Proposed Sale138.171,111153,506Mar 03 08:08 PM
Mary K. MorelandOfficerMar 03 '25Proposed Sale138.17791109,292Mar 03 07:58 PM
John A. McCoy, Jr.OfficerMar 03 '25Proposed Sale138.1756277,651Mar 03 07:52 PM
Ford Robert BCHAIRMAN AND CEOFeb 05 '25Option Exercise38.40285,38810,958,899505,447Feb 07 05:51 PM
Ford Robert BCHAIRMAN AND CEOFeb 05 '25Sale131.17285,38837,435,200220,059Feb 07 05:51 PM
Robert B. FordOfficerFeb 05 '25Proposed Sale131.17285,38837,435,238Feb 05 06:52 PM
ALLEN HUBERT LEXECUTIVE VICE PRESIDENTJan 29 '25Option Exercise38.40131,3605,044,224316,166Jan 31 07:16 PM
ALLEN HUBERT LEXECUTIVE VICE PRESIDENTJan 30 '25Option Exercise38.4058,4282,243,635243,234Jan 31 07:16 PM
ALLEN HUBERT LEXECUTIVE VICE PRESIDENTJan 29 '25Sale128.35131,36016,859,675184,806Jan 31 07:16 PM
ALLEN HUBERT LEXECUTIVE VICE PRESIDENTJan 30 '25Sale128.0758,4287,482,629184,806Jan 31 07:16 PM
Salvadori Daniel Gesua SiveEXECUTIVE VICE PRESIDENTJan 30 '25Option Exercise38.4023,771912,806149,468Jan 31 07:08 PM
Salvadori Daniel Gesua SiveEXECUTIVE VICE PRESIDENTJan 30 '25Sale128.5023,7713,054,574125,697Jan 31 07:08 PM
Morrone Louis H.EXECUTIVE VICE PRESIDENTJan 28 '25Sale127.392,644336,8190Jan 30 07:33 PM
Hubert L. AllenOfficerJan 30 '25Proposed Sale128.0758,4287,482,628Jan 30 05:33 PM
Daniel Gesua Sive SalvadoriOfficerJan 30 '25Proposed Sale128.5023,7713,054,573Jan 30 05:26 PM
Hubert L. AllenOfficerJan 29 '25Proposed Sale128.35131,36016,859,675Jan 29 05:30 PM
Funck, Jr. Robert E.OfficerNov 04 '24Proposed Sale120.0015,0001,800,000Nov 04 04:02 PM
ALLEN HUBERT LEXECUTIVE VICE PRESIDENTOct 21 '24Option Exercise47.00157,4217,398,787342,227Oct 23 05:10 PM
ALLEN HUBERT LEXECUTIVE VICE PRESIDENTOct 21 '24Sale117.04157,42118,424,298184,806Oct 23 05:10 PM
ALLEN HUBERT LOfficerOct 21 '24Proposed Sale118.89157,42118,715,783Oct 21 04:08 PM